Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
India Glycols Limited is a prominent Indian industrial manufacturer specializing in green technology-based chemicals, specialty chemicals, and natural gums. The company operates a significant life sciences division known as Ennature Biopharma, which produces a wide array of standardized herbal extracts, phytochemicals, and active pharmaceutical ingredients (APIs). Notably, it is recognized as a global leader in the production of bio-based ethylene oxide and glycols derived from renewable feedstocks. India Glycols serves the pharmaceutical, nutraceutical, and cosmeceutical industries by utilizing advanced technologies such as Supercritical Fluid Extraction (SCFE). Their portfolio includes key APIs like Thiocolchicoside and various nicotine derivatives, supporting global supply chains for healthcare and wellness products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on India Glycols.